Sánchez-Hueso M C, Mateo-Caãs J, Zamora-Madaria E
Hospital Universitario Virgen Macarena de Sevilla, Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla.
An Med Interna. 1995 May;12(5):216-20.
Plasma glucose, glycated hemoglobin lc (HbAlc), urinary albumin excretion rate (AER) and urinary N-acetyl-glucosaminidase (NAG): creatinine ratio were studied in 100 normotensive diabetic patients with no evidence of overt renal disease and in 45 controls, to find out whether the glycaemic control and incipient nephropathy may influence the urinary excretion of NAG. Twenty-three of the diabetics had microalbuminuria (group II). Group I comprised the 77 diabetics without microalbuminuria. The groups I and II of diabetics were divided into two according to plasma glucose were greater o smaller to 140 mg/dl. The group I of diabetics had greater NAG: creatinine ratio than controls, too (0.41 +/- 0.24 and 0.16 +/- 0.08 mu/mmol creatinine, p < 0.0005); in this group urinary NAG was found to positively correlate with plasma glucose and creatinine (p < 0.0005, r = 0.45). Multiple regression analysis was performed in the whole of diabetics and significant association were identified between urinary NAG excretion and plasma glucose, AER and plasma creatinine (p < 0.0005, r = 0.42). The diabetics with plasma glucose lower to 140 mg/dl had more important correlation NAG: creatinine ratio-AER (p < 0.0001, r = 0.70). It is concluded that measurement of urinary NAG may be of value in the detection of diabetic nephropathy at a potentially reversible stage if the plasma glucose is take into account.
对100例无明显肾脏疾病证据的血压正常的糖尿病患者及45例对照者的血浆葡萄糖、糖化血红蛋白lc(HbAlc)、尿白蛋白排泄率(AER)和尿N-乙酰氨基葡萄糖苷酶(NAG):肌酐比值进行了研究,以确定血糖控制和早期肾病是否会影响NAG的尿排泄。23例糖尿病患者有微量白蛋白尿(II组)。I组包括77例无微量白蛋白尿的糖尿病患者。糖尿病患者的I组和II组根据血浆葡萄糖大于或小于140mg/dl分为两组。糖尿病患者的I组NAG:肌酐比值也高于对照组(分别为0.41±0.24和0.16±0.08μ/mmol肌酐,p<0.0005);在该组中发现尿NAG与血浆葡萄糖和肌酐呈正相关(p<0.0005,r=0.45)。对所有糖尿病患者进行了多元回归分析,发现尿NAG排泄与血浆葡萄糖、AER和血浆肌酐之间存在显著关联(p<0.0005,r=0.42)。血浆葡萄糖低于140mg/dl的糖尿病患者NAG:肌酐比值与AER的相关性更显著(p<0.0001,r=0.70)。结论是,如果考虑血浆葡萄糖,测定尿NAG可能对在潜在可逆阶段检测糖尿病肾病有价值。